RxDoctor Payments Data

Adedapo Oduwole, MD

Psychiatry · Myrtle Beach, SCNPI 1720139645

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,025 of the $56,283 with a category attached, or 64.0%. AbbVie accounts for 65.3% of it on its own, with 26 other manufacturers making up the rest. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,283in general payments, 2019–2025

Across 845 payments — averaging $66.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$37K
  • Indivior Inc.$7K
  • Otsuka America Pharmaceutical, Inc.$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Neurocrine Biosciences, Inc.$1K
  • Vanda Pharmaceuticals Inc.$1K
  • plus $7K from 21 others

What the payments were for

  • Speaking & faculty fees$36,02564%
  • Travel & lodging$2,5044%
  • Food & beverage$17,67631%
  • Education$780%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,283 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Medicare billing

Part B allowed, 2024
$323,411
Medicare patients
437
Services billed
3,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate30$419,974
Austedo XrDeutetrabenazine19$163,410
VraylarCariprazine Hcl84$129,387
AustedoDeutetrabenazine12$84,844
Abilify MaintenaAripiprazole27$82,291
NuplazidPimavanserin Tartrate14$69,331
TrintellixVortioxetine Hydrobromide60$46,847
RexultiBrexpiprazole27$41,286
CaplytaLumateperone Tosylate13$23,258
Lurasidone Hcl53$21,385
AuvelityDextromethorphan Hbr/Bupropion14$16,099
Aripiprazole185$10,975
VyvanseLisdexamfetamine Dimesylate28$10,386
Duloxetine Hcl252$8,889
Venlafaxine Hcl ErVenlafaxine Hcl209$8,378

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$1,416$419,97430 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr, Austedo$1,887$248,25431 claims
AbbVieVraylar$36,749$129,38784 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$1,949$123,57754 claims
Acadia Pharmaceuticals IncNuplazid$153$69,33114 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$375$57,23388 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$942$23,25813 claims
Axsome Therapeutics, Inc.Auvelity$505$16,09914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →